EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances in Urinary Liquid Biopsy: A Review of Emerging Sensing Platforms for Early Cancer Screening and Diagnosis

Eleni Lamprou iD, Dimitrios Papakyriakou iD, Despina P Kalogianni iD

Sensors · 2026

DOI: 10.3390/s26196258 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Sensors, 2026. Verfasst von Eleni Lamprou und 2 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Chemistry & Nanotechnology Group, Department of Chemistry, University of Patras, GR-26504 Patras, Greece. Hauptthemen laut MEDLINE: Early Detection of Cancer, Biosensing Techniques, Neoplasms. Die Arbeit nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early screening of many types of cancers remains limited by the invasiveness of gold-standard tissue biopsies and the poor specificity of traditional clinical biomarkers like prostate-specific antigen (PSA). Non-invasive liquid biopsies are the emerging alternatives. Urine is one of the preferred body fluids for liquid biopsy as it offers a rich, easily accessible and large-volume source of cancer-specific metabolites, proteins, nucleic acids, extracellular vesicles, and cancer cells. This review reports the recent advancements in urinary cancer (bio)sensing technologies, including mainly optical and electrochemical platforms. To overcome the low specificity and detectability of the existing systems, novel nanomaterials, such as metal–organic frameworks, carbon dots, metal nanoparticles, and molecularly imprinted polymers, that offer increased surface area, cost-effectiveness and enzyme-free platforms, as well as accelerated electron transfer, were introduced to provide lower detection limits to the femtomolar and attomolar levels. Additionally, the integration of machine learning and artificial intelligence for biochemical “fingerprint” analysis enhanced diagnostic accuracy. Finally, we discuss the gap between novel sensing systems and robust diagnostic devices for decentralized point-of-care testing (POCT) and personalized medicine in clinical routine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Early Detection of CancerBiosensing TechniquesNeoplasmsHumansLiquid BiopsyBiomarkers, TumorProstatic NeoplasmsMetal Nanoparticles

Stichwörter der Autor:innen

biosensorbladder cancerdeep learningliquid biopsymachine learningnanotechnologyprostate cancersensorsensors artificial intelligenceurine

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Analytical Chemistry & Nanotechnology Group, Department of Chemistry, University of Patras, GR-26504 Patras, Greece.

ORCID-Profile: Eleni Lamprou, Dimitrios Papakyriakou, Despina P Kalogianni

Zitieren

APA

Lamprou, E., Papakyriakou, D., & Kalogianni, D. P. (2026). Advances in Urinary Liquid Biopsy: A Review of Emerging Sensing Platforms for Early Cancer Screening and Diagnosis. Sensors. https://doi.org/10.3390/s26196258

Vancouver

Lamprou E, Papakyriakou D, Kalogianni DP. Advances in Urinary Liquid Biopsy: A Review of Emerging Sensing Platforms for Early Cancer Screening and Diagnosis. Sensors. 2026. doi:10.3390/s26196258

BibTeX
@article{Lamprou2026,
  author = {Lamprou, Eleni and Papakyriakou, Dimitrios and Kalogianni, Despina P},
  title = {Advances in Urinary Liquid Biopsy: A Review of Emerging Sensing Platforms for Early Cancer Screening and Diagnosis},
  journal = {Sensors},
  year = {2026},
  doi = {10.3390/s26196258}
}
Kostenlos starten →